Philips settles ultrasound copyright claims
Philips has settled trade secrets and copyright claims against a medical imaging company, having already survived accusations of breaching antitrust law.
AbbVie, Taro settle over rosacea drug patents
AbbVie and its exclusive licensee have settled a patent lawsuit against Taro Pharmaceutical over a generic rosacea drug.
Illumina and Ariosa settle DNA patent dispute
Illumina and Roche-owned Ariosa Diagnostics filed a joint stipulation asking the US Supreme Court to dismiss a case concerning the eligibility of Illumina’s DNA testing patents.
Under-pressure pharma groups release vaccine scale-up plan
Several pharmaceutical organisations have joint-published a five-step plan to help provide more equitable access to COVID-19 vaccines that would avoid waiving IP rights.
UC Berkeley loses CRISPR patent at EPO
The University of California Berkeley has lost a CRISPR patent in Europe in the latest twist in the long-running IP saga over the gene-editing technology.
House passes Biden-backed orphan drug reform
The US House of Representatives has passed a bill to amend exclusivity laws for drugs on the US Food and Drug Administration’s orphan drugs list.
Takeda, Bayer settle $173m Adynovate suit
Takeda subsidiary Baxalta has agreed to drop its fightback against a $173 million award in favour of Bayer after an appeals court upheld a patent infringement win for the German conglomerate.
TTAB fast-tracks COVID TM reviews
The Trademark Trial and Appeal Board (TTAB) will start expediting the review and issuance of ex parte appeal decisions related to COVID-19 trademarks.
Roche subsidiary sues Bluebird over ‘Spark’ TM
Roche Group’s subsidiary Spark Therapeutics has filed a complaint against rival gene therapy company Bluebird Bio, accusing it of infringing its ‘Spark’ trademark.
The race to patent psychoactives
Patenting cannabinoids is an established practice in life sciences, but there are a host of other controlled substances in the field of psychoactives that companies have been rushing to patent.
